Open AccessCan Prostate-Specific Antigen Density Be an Index to Distinguish Patients Who Can Omit Repeat Prostate Biopsy in Patients with Negative Magnetic Resonance Imaging?
Author(s) -
Jiwoong Yu,
Youngjun Boo,
Minyong Kang,
Hyun Hwan Sung,
Byong Chang Jeong,
Seongil Seo,
Seong Soo Jeon,
Hyun-Moo Lee,
Hwang Gyun Jeon
Publication year - 2021
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
ISSN - 1179-1322
DOI - 10.2147/cmar.s318404
Subject(s) - biopsy , medicine , prostate cancer , prostate biopsy , prostate , prostate specific antigen , urology , magnetic resonance imaging , radiology , logistic regression , cancer
We evaluated the negative predictive value (NPV) of multiparametric magnetic resonance imaging (mpMRI) in detecting clinically significant prostate cancer (csPCa) according to biopsy setting and prostate-specific antigen density (PSAD) using transperineal template-guided saturation prostate biopsy (TPB) as the reference standard.